Erin Marie Gumm, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 105 W Ohio St, Toledo, IA 52342 Phone: 641-691-1159 |
News Archive
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
Recommendations to reduce federal health care spending in a socially and fiscally responsible manner today were made in a letter to the Congressional Joint Committee on Deficit Reduction from the American College of Physicians.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have achieved a major milestone with the launch of two clinical trials testing an experimental therapy in which patients' own immune cells are genetically engineered to fight their cancer.
Biologics-na-ve Juvenile Idiopathic Arthritis patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Results of an additional study, which researched a small cohort of patients showed an increased frequency of cancer in those receiving the biologic etanercept, however, results were deemed not statistically significant by researchers.
› Verified 8 days ago